ACER THERAPEUTICS INC. — Operating Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/682508e5-8f4a-40a5-8f2c-0fa9361fa87b/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-24.6M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-009992 |
| FY 2021 | $-15.9M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-008350 |
| FY 2020 | $-22.8M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-009909 |
| FY 2019 | $-29.9M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-011639 |
| FY 2018 | $-21.7M | 2018-01-01 – 2018-12-31 | evidence 0001564590-20-011639 |
| FY 2017 | $-13.9M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-004714 |
| FY 2016 | $-6.7M | 2016-01-01 – 2016-12-31 | evidence 0001564590-18-004714 |
| FY 2015 | $-12.1M | 2015-01-01 – 2015-12-31 | evidence 0001354488-16-006584 |
| FY 2014 | $-15.1M | 2014-01-01 – 2014-12-31 | evidence 0001157523-15-000646 |
| FY 2013 | $-124.4M | 2003-01-23 – 2014-03-31 | evidence 0001157523-14-002173 |
| FY 2012 | $-111.4M | 2003-01-23 – 2013-03-31 | evidence 0001157523-13-002641 |
| FY 2011 | $-102.0M | 2003-01-22 – 2012-03-31 | evidence 0001157523-12-002801 |
| FY 2010 | $-5.0M | 2010-01-01 – 2010-12-31 | evidence 0001157523-12-001047 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).